Pretty good patent news! It shouldn't take this much work to cut a flawed patent down to harmless size, but @mccoysm and @tobbelobb are heroes for doing it.
Big congrats and big thanks. 👏🏆🦸
Posting below by a client who hired me to challenge a patent on a community's open source (GPL) 3D printing device.
Shows how often the most expensive alternative is suggested, or people are told not to even try.
H/T referral from Alex Moss @PublicPatent.
torbjornludvigsen.com/blog/2…
More early xmas gifts for big pharma and patent trolls: stopping public interest groups from challenging and judges with technical expertise from cancelling invalid patents.
coons.senate.gov/news/press-…
[1/2]
1
6
985
It shouldn't be controversial to require a patented invention to be "new." But Chris Coons and Thom Tillis literally want to take that requirement out of the law.
tillis.senate.gov/services/f…
Wonder how the COVID pandemic would have been under the Coons-Tillis bill?
[1/8]
If Coons, Tillis, & big pharma win, when the next pandemic comes, we'll be back in the pre-Myriad world. Companies will have be able to monopolize gene sequences they didn't create and use them to control access to biological information on which our lives depend.
[7/8]
1
2
151
The Patent Office should be protecting the people invalid patents harm, not the companies that rely on them to profit off productive--and genuinely creative--efforts of others.
Help us remind them to put the public's interest first.
Together, we can protect the public's right to challenge invalid patents that harm countless Americans each year, especially those who depend on heavily patented drugs and medical devices.
To submit comments: federalregister.gov/document…
For more info: piplius.org/news/save-the-pu…
So excited to be a part of this important conversation about patents & drug prices-please join!
Want to learn how the patent system drives up drug prices and what you can do about it?
Join the conversation with @waxmanstrategies, @IMAKglobal, & us this Wednesday at 2pm ET.
More info below and registration here: tinyurl.com/RxPatentWebinar
Thanks to @EFF and @Joemullin, there's an easy way to stand up for the public's right to challenge patents that shouldn't exist (and a great explanation of why we need to): eff.org/deeplinks/2023/06/ou….
SCOTUS just saved enablement law and the health of patients with heart disease taking Praluent. Maybe its patented rival, Repatha, will get cheaper too. 👏
Now, to get the USPTO to reject applications that don't enable others to make what they claim...
supremecourt.gov/opinions/22…
2
154
How did the government lose a jury trial on infringement?
Some patent claims were so broad they just required giving the components of Gilead's drug to a primate without an immunodeficiency retrovirus.
The trial transcripts can't come soon enough.
This quoted post is unavailable.
3
346
Listening now, and amazed how often Director Vidal offers to speak "off line" and "off the record" instead of answering questions directly. Why can't she talk openly about the the PTO's authority to issue discretionary denials?
The House Judiciary Committee will hold a hearing tomorrow, Thursday at 9AM ET with @USPTO Director Kathi Vidal to gather info & updates regarding the implementation of recent legislation and policymaking processes. Livestream ↓
judiciary.house.gov/committe…
We're calling on Congress to protect our ability to challenge invalid patents that thwart competition, spike prices, and spur litigation -- with @uspirg , @Public_Citizen, @RSI @t1international, @MichiganUnited, & Public Innovation Project.
Our letter: https://xitter.gq/t.co/7N95mv9vnw
Given the one-sided hearing that happened this week, PIRG's report on patent abuse and drug pricing is more important than ever: pirg.org/resources/the-cost-…
Patent cases are goldmines for litigation funders and may be strategic tools for foreign governments. We need more transparency now. dcjournal.com/a-wake-up-call…





